A new study shows that brain connectivity patterns, especially in the dorsal anterior cingulate cortex, can help predict how ...

The murder trial of Uganda vs Molly Katanga and Four Others resumed last Monday with the twelfth prosecution witness, Dr ...

Our coffee briefing covers a £2m robot surgeon at University Hospitals Coventry and Warwickshire, funding for UK biotech and updates to eFI.

The DRML Miner system is a mining platform based on cloud computing and using clean energy. Users can mine remotely through ...

Traditionally used by Native American communities, Black Cohosh has become a well-known herb for supporting women's comfort ...

The best smart bird feeders with cameras generate detailed videos and photos and use AI identification. Our top picks are ...

Induced Nausea and Vomiting Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth ...

DelveInsight's "Metastatic Cutaneous Squamous Cell Cancer Market Insights, Epidemiology, and Market Forecast- 2032" report ...

Bioxodes has stopped enrolling people in a phase 2a stroke study after hitting the safety and efficacy endpoints, positioning the Belgian biotech to power into a potentially registrational trial.

The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to develop the molecule as a monotherapy. Led by AbbVie’s Humira, biologic TNF ...

Immix Biopharma, Inc. has announced that interim data from its Phase 1/2 NEXICART-2 trial of the CAR-T therapy ... Disclaimer: This is an AI-generated summary of a press release distributed ...

Two agents targeting angiopoietin-like protein 3 safely lowered lipid levels in phase 2 trials. Solbinsiran and SHR-1918 will be further studied in patients with high lipid levels in phase 3 trials.